Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Gastrointestinal Oncology


Led by Editors-in-Chief Irit Ben-Aharon and Florian Lordick, ESMO Gastrointestinal Oncology is a new, peer-reviewed, open access journal from ESMO.

It is the European Society for Medical Oncology's latest peer-reviewed open access journal, dedicated to publishing high-quality research and commenting on all aspects of the diagnosis, treatment and understanding of gastrointestinal cancers.

Access the journal

The journal aims to publish experimental, translational, diagnostic and therapeutic research. Specific areas of interest include but are not limited to gastrointestinal cancer biology and epidemiology, prevention and early detection, advances in molecular, genetic and imaging diagnostics, therapeutic studies from pre-clinical to clinical (phase I-IV) with a focus on targeted and immunotherapy, translational research, patient-oriented studies, psychosocial aspects of disease, treatment of long-term morbidity and survivorship, palliative and supportive care, novel methods and clinical protocols. The journal welcomes original articles, reviews, mini reviews, editorials, research methods and clinical trial summaries, and correspondence. In addition, it provides in-depth commentaries from leading experts and engages in active debate on important topics via its pro and con discussion section.

ESMO Gastrointestinal Oncology is committed to providing swift review and publication supported by our team of experienced international experts and key opinion leaders. The journal will provide essential reading for cancer researchers, clinician-scientists, clinicians with a focus gastrointestinal cancer, patient advocates and all health care professionals with a specific interest in gastrointestinal cancers. The journal rapidly disseminates the best innovative clinical and translational research and aims to improve the quality of education, prevention, diagnosis, treatment and patient care worldwide.

ESMO members are entitled to a discount on the article publicaction charge; for more details visit this page

Find out more about joining ESMO

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.